Sustainable Membrane System for Efficient WFI Production in Pharmaceuticals

Asahi Kasei has launched a membrane-based system designed to produce Water for Injection (WFI), a sterile water essential for injection preparation, as a sustainable alternative to traditional distillation. Developed with Microza™ hollow-fiber membrane technology, known for high performance in water and liquid filtration, this system minimizes steam generation, cutting both CO2 emissions and operational costs.
Widely respected in the pharmaceutical industry, Microza™ membranes deliver efficient filtration and robust technical support, establishing them as a preferred solution for pharmaceutical water applications. The WFI system employs steam-sterilizable ultrafiltration membranes, compactly designed for ease of use and enhanced operational efficiency. Compared to distillation, this membrane process eliminates the need for cooling and condensation steps, streamlining production and boosting water quality.
​By transitioning to membrane-based filtration, Asahi Kasei aims to offer the pharmaceutical industry a reliable and safer WFI production method that lowers emissions and maintains a steady supply.
For more and inquiries about the product, visit the company page here